Company profile · free preview

Sol-Gel Technologies Ltd.

SLGL · NASDAQ · Healthcare · Updated 11/13/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about Sol-Gel Technologies Ltd.'s filings — free.

Create free account

Sol-Gel Technologies Ltd. return on capital (fiscal 2025)

ROIC

—

Return on capital

—

Return on equity

-23.7%

Return on assets

-18.6%

Gross margin

—

Operating margin

-38.9%

Net debt / EBITDA

1.49x

Sol-Gel Technologies Ltd. insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-09-11Opaleye Management Inc.Purchase1,493$65.94
2026-09-10Opaleye Management Inc.Purchase1,631$66.80
2026-09-09Opaleye Management Inc.Purchase3,097$68.70
2026-09-08Opaleye Management Inc.Purchase471$69.37
2026-09-08Opaleye Management Inc.Purchase3,390$68.74
2026-09-04Opaleye Management Inc.Purchase2,100$68.98
2026-09-04Opaleye Management Inc.Purchase918$69.52
2026-09-02Opaleye Management Inc.Purchase900$68.95

SEC filings

No filings stored yet.

Ask anything about Sol-Gel Technologies Ltd.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare SLGL head-to-head

More Healthcare companies